Selected research
Industry Research
Artificial Blood Products Industry Research Report 2026
Market perspective
The global Artificial Blood Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Artificial Blood Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Artificial Blood Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Artificial Blood Products include SpheriTech Ltd., NuvOx Pharma, KaloCyte Inc., HEMARINA SA, HbO2 Therapeutics and Aurum Biosciences Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Artificial Blood Products market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Blood Products Market by Company
SpheriTech Ltd.
NuvOx Pharma
KaloCyte Inc.
HEMARINA SA
HbO2 Therapeutics
Aurum Biosciences Ltd.
Artificial Blood Products Segment by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Artificial Blood Products Segment by Application
Military
Civil
Artificial Blood Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artificial Blood Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artificial Blood Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Perfluorocarbon-based Oxygen Carrier (PFBOC)
- Hemoglobin-based Oxygen Carrier (HBOC)
Applications
- Military
- Civil
Companies covered
- SpheriTech Ltd.
- NuvOx Pharma
- KaloCyte Inc.
- HEMARINA SA
- HbO2 Therapeutics
- Aurum Biosciences Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Artificial Blood Products Market Size (2021-2032)
- 2.2.2 Global Artificial Blood Products Sales (2021-2032)
- 2.2.3 Global Artificial Blood Products Market Average Price (2021-2032)
- 2.3 Artificial Blood Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
- 2.3.3 Hemoglobin-based Oxygen Carrier (HBOC)
- 2.4 Artificial Blood Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Military
- 2.4.3 Civil
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artificial Blood Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Artificial Blood Products Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Artificial Blood Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Artificial Blood Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Artificial Blood Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Artificial Blood Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Artificial Blood Products, Product Type & Application
- 3.8 Global Manufacturers of Artificial Blood Products, Established Date
- 3.9 Global Artificial Blood Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SpheriTech Ltd.
- 4.1.1 SpheriTech Ltd. Company Information
- 4.1.2 SpheriTech Ltd. Business Overview
- 4.1.3 SpheriTech Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 SpheriTech Ltd. Artificial Blood Products Product Portfolio
- 4.1.5 SpheriTech Ltd. Recent Developments
- 4.2 NuvOx Pharma
- 4.2.1 NuvOx Pharma Company Information
- 4.2.2 NuvOx Pharma Business Overview
- 4.2.3 NuvOx Pharma Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 NuvOx Pharma Artificial Blood Products Product Portfolio
- 4.2.5 NuvOx Pharma Recent Developments
- 4.3 KaloCyte Inc.
- 4.3.1 KaloCyte Inc. Company Information
- 4.3.2 KaloCyte Inc. Business Overview
- 4.3.3 KaloCyte Inc. Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 KaloCyte Inc. Artificial Blood Products Product Portfolio
- 4.3.5 KaloCyte Inc. Recent Developments
- 4.4 HEMARINA SA
- 4.4.1 HEMARINA SA Company Information
- 4.4.2 HEMARINA SA Business Overview
- 4.4.3 HEMARINA SA Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 HEMARINA SA Artificial Blood Products Product Portfolio
- 4.4.5 HEMARINA SA Recent Developments
- 4.5 HbO2 Therapeutics
- 4.5.1 HbO2 Therapeutics Company Information
- 4.5.2 HbO2 Therapeutics Business Overview
- 4.5.3 HbO2 Therapeutics Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HbO2 Therapeutics Artificial Blood Products Product Portfolio
- 4.5.5 HbO2 Therapeutics Recent Developments
- 4.6 Aurum Biosciences Ltd.
- 4.6.1 Aurum Biosciences Ltd. Company Information
- 4.6.2 Aurum Biosciences Ltd. Business Overview
- 4.6.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio
- 4.6.5 Aurum Biosciences Ltd. Recent Developments
5 Global Artificial Blood Products Market Scenario by Region
- 5.1 Global Artificial Blood Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artificial Blood Products Sales by Region: 2021-2032
- 5.2.1 Global Artificial Blood Products Sales by Region: 2021-2026
- 5.2.2 Global Artificial Blood Products Sales by Region: 2027-2032
- 5.3 Global Artificial Blood Products Revenue by Region: 2021-2032
- 5.3.1 Global Artificial Blood Products Revenue by Region: 2021-2026
- 5.3.2 Global Artificial Blood Products Revenue by Region: 2027-2032
- 5.4 North America Artificial Blood Products Market Facts & Figures by Country
- 5.4.1 North America Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Artificial Blood Products Sales by Country (2021-2032)
- 5.4.3 North America Artificial Blood Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Artificial Blood Products Market Facts & Figures by Country
- 5.5.1 Europe Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Artificial Blood Products Sales by Country (2021-2032)
- 5.5.3 Europe Artificial Blood Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Artificial Blood Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Artificial Blood Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Artificial Blood Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Artificial Blood Products Market Facts & Figures by Country
- 5.7.1 South America Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Artificial Blood Products Sales by Country (2021-2032)
- 5.7.3 South America Artificial Blood Products Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Artificial Blood Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Artificial Blood Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Artificial Blood Products Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Artificial Blood Products Sales by Type (2021-2032)
- 6.1.1 Global Artificial Blood Products Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Artificial Blood Products Sales Market Share by Type (2021-2032)
- 6.2 Global Artificial Blood Products Revenue by Type (2021-2032)
- 6.2.1 Global Artificial Blood Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Artificial Blood Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Artificial Blood Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Artificial Blood Products Sales by Application (2021-2032)
- 7.1.1 Global Artificial Blood Products Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Artificial Blood Products Sales Market Share by Application (2021-2032)
- 7.2 Global Artificial Blood Products Revenue by Application (2021-2032)
- 7.2.1 Global Artificial Blood Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Artificial Blood Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Artificial Blood Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Artificial Blood Products Value Chain Analysis
- 8.1.1 Artificial Blood Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Artificial Blood Products Production Mode & Process
- 8.2 Artificial Blood Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Artificial Blood Products Distributors
- 8.2.3 Artificial Blood Products Customers
9 Global Artificial Blood Products Analyzing Market Dynamics
- 9.1 Artificial Blood Products Industry Trends
- 9.2 Artificial Blood Products Industry Drivers
- 9.3 Artificial Blood Products Industry Opportunities and Challenges
- 9.4 Artificial Blood Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst